Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GANSER A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 230 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Scherr, M; LeBon, J; Castanotto, D; Cunliffe, HE; Meltzer, PS; Ganser, A; Riggs, AD; Rossi, JJ
      Detection of antisense and ribozyme accessible sites on native mRNAs: Application to NCOA3 mRNA

      MOLECULAR THERAPY
    2. Trummer, A; Hertenstein, B; Lichtinghagen, R; Ganser, A; Arseniev, L
      Evaluation of a device for negative selection of CD34+cells alone or in combination with breast cancer tumor cell purging

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    3. Krauter, J; Hoellge, W; Wattjes, MP; Nagel, S; Heidenreich, O; Bunjes, D; Ganser, A; Heil, G
      Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR

      GENES CHROMOSOMES & CANCER
    4. Tacke, F; Schoffski, P; Trautwein, C; Manns, MP; Ganser, A; von Depka, M
      Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease

      BLOOD COAGULATION & FIBRINOLYSIS
    5. Verbeek, W; Ganser, A
      Evolving treatment options of myelodysplastic syndromes

      ANNALS OF HEMATOLOGY
    6. Volk, J; Reinke, F; van Kuilenburg, ABP; van Gennip, AH; Schlichting, C; Ganser, A; Schoffski, P
      Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer

      ANNALS OF ONCOLOGY
    7. Grunwald, V; Blanc, SL; Karstens, JH; Weihkopf, T; Kuske, M; Ganser, A; Schoffski, P
      Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin

      ANNALS OF ONCOLOGY
    8. Scherr, M; Battmer, K; Blomer, U; Ganser, A; Grez, M
      Quantitative determination of lentiviral vector particle numbers by real-time PCR

      BIOTECHNIQUES
    9. Hambach, L; Eder, M; Dammann, E; Battmer, K; Stucki, A; Heil, G; Ganser, A; Hertenstein, B
      Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia

      BONE MARROW TRANSPLANTATION
    10. Schoffski, P; Ganser, A
      Bendamustine - A viewpoint

      DRUGS
    11. Jaeger, K; Osthaus, A; Heine, J; Ruschulte, H; Kuhlmann, C; Weissbrodt, H; Ganser, A; Karthaus, M
      Efficacy of a benzalkonium chloride-impregnated central venous catheter toprevent catheter-associated infection in cancer patients

      CHEMOTHERAPY
    12. Wagner, K; Kafert-Kasting, S; Heil, G; Ganser, A; Eder, M
      Inhibition of granulocyte-macrophage colony-stimulating factor receptor function by a splice variant of the common beta-receptor subunit

      BLOOD
    13. Rohrig, G; Engel, H; Noack, F; Ganser, A; Peest, D
      Mixed Variant of Castleman's Disease: an exceptional diagnosis in a patient with weakness, weight-loss, and night-sweat

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    14. Studt, JD; Budde, U; Schneppenheim, R; Eisert, R; Prondzinski, MV; Ganser, A; Barthels, M
      Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry

      AJCP. American journal of clinical pathology
    15. Krauter, J; Wattjes, MP; Nagel, S; Heidenreich, O; Krug, U; Kafert, S; Bunjes, D; Bergmann, L; Ganser, A; Heil, G
      Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in patients with t(8;21) positive AML

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    16. Karthaus, M; Doellmann, T; Klimasch, T; Krauter, J; Heil, G; Ganser, A
      Incidence of central venous catheter (CVC)-infections in patients with acute leukemia

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    17. Trummer, A; Kadar, J; Arseniev, L; Petersen, D; Ganser, A; Lichtinghagen, R
      Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    18. Krombach, G; Ganser, A; Fricke, C; Rohde, V; Reinges, M; Gilsbach, J; Spetzger, U
      Virtual placement of frontal ventricular catheters using frameless neuronavigation: an "unbloody training" for young neurosurgeons

      MINIMALLY INVASIVE NEUROSURGERY
    19. Schoffski, P; Ganser, A; Pascheberg, U; Busche, G; Gaede, B; Hertenstein, B
      Complete haematological and cytogenetic response to interferon alpha-2a ofa myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration

      ANNALS OF HEMATOLOGY
    20. Heil, G; Krauter, J; Westphal-Frosch, C; Ganser, A
      Immunoelectron microscopic analysis of CD 54 surface distribution and its role in homotypic interaction on normal monocytes and blasts of acute myeloid leukemia

      ANNALS OF HEMATOLOGY
    21. Ganser, A; Heil, G; Seipelt, G; Hofmann, W; Fischer, JT; Langer, W; Brockhaus, W; Kolbe, K; Ittel, H; Brack, N; Fuhr, HG; Knuth, P; Hoffken, K; Bergmann, L; Hoelzer, D
      Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)

      ANNALS OF HEMATOLOGY
    22. Schoffski, P; Seeland, G; Engel, H; Grunwald, V; Paul, H; Merkle, K; Kowalski, R; Ganser, A
      Weekly administration of bendamustine: A phase I study in patients with advanced progressive solid tumours

      ANNALS OF ONCOLOGY
    23. Gokbuget, N; Hoelzer, D; Arnold, R; Bohme, A; Bartram, CR; Freund, M; Ganser, A; Kneba, M; Langer, W; Lipp, T; Ludwig, WD; Maschmeyer, G; Rieder, H; Thiel, E; Weiss, A; Messerer, D
      Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    24. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
      Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

      LEUKEMIA
    25. Wattjes, MP; Krauter, J; Nagel, S; Heidenreich, O; Ganser, A; Heil, G
      Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positiveacute myelogenous leukemia

      LEUKEMIA
    26. Schoffski, P; Hagedorn, T; Grunwald, V; Paul, H; Merkle, K; Kowalski, R; Ganser, A
      Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    27. Rosenthal, C; Karthaus, M; Ganser, A
      New strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis

      SUPPORTIVE CARE IN CANCER PATIENTS: RECENT DEVELOPMENTS
    28. Prondzinski, MV; Karthaus, M; Ganser, A; Barthels, M
      Anticoagulant prophylaxis and therapy in patients with cancer

      SUPPORTIVE CARE IN CANCER PATIENTS: RECENT DEVELOPMENTS
    29. Seidl, C; Siehl, J; Ganser, A; Hofmann, WK; Fischer, M; Kirchmaier, CM; Hoelzer, D; Seifried, E
      Platelet glycoprotein expression in patients with myelodysplastic syndrome

      THROMBOSIS RESEARCH
    30. Huebner, G; Karthaus, M; Pethig, K; Freund, M; Ganser, A
      Myelodysplastic syndrome and acute myelogenous leukemia secondary to hearttransplantation

      TRANSPLANTATION
    31. Karthaus, M; Doellmann, T; Klimasch, T; Elser, C; Rosenthal, C; Ganser, A; Heil, G
      Intensive intravenous amphotericin B for prophylaxis of systemic fungal infections - Results of a prospective controlled pilot study in acute leukemia patients

      CHEMOTHERAPY
    32. Karthaus, M; Ganser, A
      Hepatosplenic candidiasis in patients with acute leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    33. von Depka, M; Nowak-Gottl, U; Eisert, R; Dieterich, C; Barthels, M; Scharrer, I; Ganser, A; Ehrenforth, S
      Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

      BLOOD
    34. Arseniev, L; Pickerd, N; Goudeva, L; Hertenstein, B; Ganser, A
      Comparative evaluation of commonly used clones and fluorochrome conjugatesof monoclonal antibodies for CD34 antigen detection

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    35. Duensing, S; Duensing, A; Meran, JG; Kreft, A; Busche, G; Ganser, A; Georgii, A
      Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    36. Ehrenforth, S; Prondsinski, MV; Aygoren-Pursun, E; Scharrer, I; Ganser, A
      Study of the prothrombin gene 20201 GA variant in FV : Q(506) carriers in relationship to the presence or absence of juvenile venous thromboembolism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    37. Wilkens, L; Burkhardt, D; Tchinda, J; Busche, G; Werner, M; Nolte, M; Ganser, A; Georgii, A
      Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization

      DIAGNOSTIC MOLECULAR PATHOLOGY
    38. Venturini, L; You, J; Stadler, M; Galien, R; Lallemand, VR; Koken, MHM; Mattei, MG; Ganser, A; Chambon, P; Losson, R; de The, H
      TIF1 gamma, a novel member of the transcriptional intermediary factor 1 family

      ONCOGENE
    39. Ganser, A; Wynns, KA; Kurlekar, A
      Operational experience with diffusion coatings on steam cracker tubes

      MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
    40. Krauter, J; Ganser, A; Bergmann, L; Raghavachar, A; Hoelzer, D; Lubbert, M; Schlimok, G; Arnold, R; Kirchner, H; Port, M; Heil, G
      Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML

      ANNALS OF HEMATOLOGY
    41. Hofmann, WK; Ganser, A; Seipelt, G; Ottmann, OG; Zander, C; Geissler, G; Hoffmann, K; Hoffken, K; Fischer, JT; Isele, G; Hoelzer, D
      Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

      ANNALS OF HEMATOLOGY
    42. Schoffski, P; Chollet, P; Ganser, A; Wiese, KH; Rambusch, E; de Vries, MJ; Hanauske, A
      Complete response of a gastric primary after a short but toxic course of 'S-1'

      ANNALS OF ONCOLOGY
    43. Eder, M; Battmer, K; Kafert, S; Stucki, A; Ganser, A; Hertenstein, B
      Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation

      LEUKEMIA
    44. Franzke, A; Peest, D; Probst-Kepper, M; Buer, J; Kirchner, GI; Brabant, G; Kirchner, H; Ganser, A; Atzpodien, J
      Autoimmunity resulting from cytokine treatment predicts long-term survivalin patients with metastatic renal cell cancer

      JOURNAL OF CLINICAL ONCOLOGY
    45. Karthaus, M; Boehme, A; Ganser, A; Juergens, H
      Important aspects of cost-effectiveness analysis in febrile neutropenia

      INFECTION
    46. Karthaus, M; Rosenthal, C; Ganser, A
      Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies?

      BONE MARROW TRANSPLANTATION
    47. Meyer, N; Duensing, S; Anastassiou, G; Nunez, FB; Grosse, J; Ganser, A; Atzpodien, J
      Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastine

      ANTICANCER RESEARCH
    48. Ganser, A
      Finally progress in the understanding of myelodysplastic syndromes?

      WIENER KLINISCHE WOCHENSCHRIFT
    49. Barthels, M; Kraus, M; Bohn, U; Liese, B; von Depka, M; Eisert, R; Ganser, A
      Factor VIII inhibitor-tests could be less sensitive than supposed

      VOX SANGUINIS
    50. Schoffski, P; Tacke, F; Ganser, A; Trautwein, C; Martin, MU; Petersen, D
      Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels

      TRANSFUSION
    51. Kafert, S; Luther, S; Boll, I; Wagner, K; Ganser, A; Eder, M
      Functional analysis of a single chain chimeric alpha/beta-granulocyte-macrophage colony-stimulating factor receptor - Importance of a glutamate residue in the transmembrane region

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. Krauter, J; Wattjes, MP; Nagel, S; Heidenreich, O; Krug, U; Kafert, S; Bunjes, D; Bergmann, L; Ganser, A; Heil, G
      Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients

      BRITISH JOURNAL OF HAEMATOLOGY
    53. Tacke, F; Schoffski, P; Trautwein, C; Martin, MU; Stangel, W; Seifried, E; Manns, MP; Ganser, A; Petersen, D
      Endogenous serum levels of thrombopoietic cytokines in healthy whole-bloodand platelet donors: implications for plateletpheresis

      BRITISH JOURNAL OF HAEMATOLOGY
    54. Wittke, F; Hoffmann, R; Buer, J; Dallmann, I; Oevermann, K; Sel, S; Wander, T; Ganser, A; Atzpodien, J
      Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma

      BRITISH JOURNAL OF CANCER
    55. Hoffmann, R; Franzke, A; Buer, J; Sel, S; Oevermann, K; Duensing, A; Probst, M; Duensing, S; Kirchner, H; Ganser, A; Atzpodien, J
      Prognostic impact of in vivo soluble cell adhesion molecules in metastaticrenal cell carcinoma

      BRITISH JOURNAL OF CANCER
    56. Karthaus, M; Ganser, A
      Clinical use of hematopoietic growth factors in urological malignancies

      AKTUELLE UROLOGIE
    57. Ehrenforth, S; Klinke, S; Prondzinski, MVD; Kreuz, W; Ganser, A; Scharrer, I
      Resistance to activated protein C in patients with deep vein thrombosis and or pulmonary embolism: molecular genetic study of prevalence among patients from various regions in Germany

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    58. Duensing, S; Nasarek, A; Grosse, J; Ganser, A; Atzpodien, J
      Elevated plasma levels of interleukin-1 receptor antagonist are associatedwith decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemia

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    59. ARSENIEV L; HERTENSTEIN B; LINK H; GANSER A; SERKE S
      STEM-CELL MOBILIZATION IN NORMAL DONORS

      Journal of hematotherapy
    60. BECKER S; WASSER S; HAUSES M; HOSSLE JP; OTT MG; DINAUER MC; GANSER A; HOELZER D; SEGER R; GREZ M
      CORRECTION OF RESPIRATORY BURST ACTIVITY IN X-LINKED CHRONIC GRANULOMATOUS CELLS TO THERAPEUTICALLY RELEVANT LEVELS AFTER GENE-TRANSFER INTO BONE-MARROW CD34(+) CELLS

      Human gene therapy
    61. ARSENIEV L; PICKERD N; GANSER A
      AN ALTERNATIVE MULTICOLOR COMPENSATION METHOD FOR THE SAMPLE-DIRECTEDIMMUNE PHENOTYPING OF CD34(-CYTOMETRY - A TECHNICAL NOTE() CELLS VIA FLOW)

      Infusionstherapie und Transfusionsmedizin
    62. SCHERR M; MAURER AB; KLEIN S; GANSER A; ENGELS JW; GREZ M
      EFFECTIVE REVERSAL OF A TRANSFORMED PHENOTYPE BY RETROVIRUS-MEDIATED TRANSFER OF A RIBOZYME DIRECTED AGAINST MUTANT N-RAS

      Gene therapy
    63. SCHOFFSKI P; FREUND M; WUNDER R; PETERSEN D; KOHNE CH; HECKER H; SCHUBERT U; GANSER A
      SAFETY AND TOXICITY OF AMPHOTERICIN-B IN GLUCOSE 5-PERCENT OR INTRALIPID 20-PERCENT IN NEUTROPENIC PATIENTS WITH PNEUMONIA OR FEVER OF UNKNOWN ORIGIN - RANDOMIZED STUDY

      BMJ. British medical journal
    64. FISCHER T; NEUBAUER A; MOHM J; HUHN D; BUSEMANN C; LINK H; ARSENIEV L; BUSSING B; NOVOTNY J; GANSER A; DUYSTER J; BUNJES D; WESTERMEIER T; FLOHR T; DESPRES D; GAMM H; DECKER J; DERIGS G; AULITZKY W; HUBER C
      OUTCOME OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN ADVANCED PHASESOF CML IS DEPENDENT ON THE TYPE OF CHEMOTHERAPY APPLIED

      Annals of hematology
    65. KARTHAUS M; HUEBNER G; ELSER C; GEISSLER RG; HEIL G; GANSER A
      EARLY DETECTION OF CHRONIC DISSEMINATED CANDIDA INFECTION IN LEUKEMIAPATIENTS WITH FEBRILE NEUTROPENIA - VALUE OF COMPUTER-ASSISTED SERIALULTRASOUND DOCUMENTATION

      Annals of hematology
    66. SCHOFFSKI P; RIETH A; WEIHKOPF T; KOWALSKI R; HAGEDORN T; GANSER A
      BENDAMUSTINE - A WELL TOLERATED ALKYLATING AGENT WITH HIGH-ACTIVITY IN LYMPHOMAS AND SOLID TUMORS

      Annals of oncology
    67. KARTHAUS M; HUEBNER G; ELSER C; GEISSLER RG; HEIL G; GANSER A
      DETECTION OF CHRONIC SYSTEMIC CANDIDA INFECTION IN LEUKEMIA PATIENTS WITH FEBRILE NEUTROPENIA - VALUE OF COMPUTER-ASSISTED SERIAL ULTRASOUND DOCUMENTATION

      European journal of haematology
    68. ENGELS JW; SCHERR M; GANSER A; GREZ M; WITTMANN V
      MODIFIED HAMMERHEAD RIBOZYMES AS POTENTIAL THERAPEUTICS

      Nucleosides & nucleotides
    69. CAZZOLA M; ANDERSON JE; GANSER A; HELLSTROMLINDBERG E
      A PATIENT-ORIENTED APPROACH TO TREATMENT OF MYELODYSPLASTIC SYNDROMES

      Haematologica
    70. Karthaus, M; Huebner, G; Ganser, A
      Improvement in the management of cancer patients: Digital ultrasound documentation

      ONKOLOGIE
    71. KIRCHNER GI; FRANZKE A; BUER J; BEIL W; PROBSTKEPPER M; WITTKE F; OVERMANN K; LASSMANN S; HOFFMANN R; KIRCHNER H; GANSER A; ATZPODIEN J
      PHARMACOKINETICS OF RECOMBINANT HUMAN INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA PATIENTS FOLLOWING SUBCUTANEOUS APPLICATION

      British journal of clinical pharmacology
    72. KARTHAUS M; ROSENTHAL C; HUEBNER G; PAUL H; ELSER C; HERTENSTEIN B; KRAUTER J; SCHARMANN T; GEISSLER RG; HEIL G; GANSER A
      EFFECT OF TOPICAL ORAL G-CSF ON ORAL MUCOSITIS - A RANDOMIZED PLACEBO-CONTROLLED TRIAL

      Bone marrow transplantation
    73. ARSENIEV L; LINK H; DIEDRICH H; NOVOTNY J; GANSER A; HERTENSTEIN B
      CONSECUTIVE TRANSPLANTATION OF PURIFIED ALLOGENEIC CD34(-CELLS EX-VIVO EXPANDED ALLOGENEIC CELLS, OR ESCALATING DOSAGES OF DONOR LYMPHOCYTETRANSFUSIONS - A CONCEPT FOR ALLOGENEIC COMPONENT TRANSPLANTATION() BLOOD)

      Bone marrow transplantation
    74. FREUND M; HEIL G; ARNOLD R; BALLEISEN L; BUCHNER T; DIEDRICH H; EIMERMACHER H; FONATSCH C; GANSER A; GASSMANN W; HARTMANN F; HIDDEMANN W; KASPER C; KNAUF WU; KOCH P; KUBICA U; LINK H; LOFFLER H; LUDWIG WD; MASCHMEYER G; POMPE K; SCHADECK C; SCHMITZ N; SCHONROCKNABULSI P; SCHWONZEN M; THIEL E; WEISS A; HOELZER D
      THE ROLE OF BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY INRELAPSING ACUTE LYMPHOCYTIC-LEUKEMIA

      Bone marrow transplantation
    75. FISCHER T; NEUBAUER A; MOHM J; HUHN D; BUSEMANN C; LINK H; ARSENIEV L; BUSSING B; NOVOTNY J; GANSER A; DUYSTER J; BUNJES D; KREITER S; AULITZKY W; HEHLMANN R; HUBER C
      CHEMOTHERAPY-INDUCED MOBILIZATION OF KARYOTYPICALLY NORMAL PBSC FOR AUTOGRAFTING IN CML

      Bone marrow transplantation
    76. NOVOTNY J; SCHRODER D; PETERSEN D; DIEDRICH H; ARSENIEV L; GANSER A; KADAR J; HERTENSTEIN B
      DECREASE OF PERIPHERAL-BLOOD LYMPHOCYTES AFTER ALLOGENEIC PBSC APHERESESIS IS SUSTAINED AND CORRELATED CUMULATIVE LYMPHOCYTE LOSS

      Bone marrow transplantation
    77. NOVOTNY JR; BATTMER K; STUCKI A; ARSENIEV L; BUNJES D; WIESNETH M; HALE G; GANSER A; HERTENSTEIN B
      REDUCTION OF EARLY HAEMATOGENETIC PROGENITORS IN T-CELL DEPLETION BY CAMPATH-1M BUT NOT BY CAMPATH-1H

      Bone marrow transplantation
    78. NOVOTNY J; GABRYSIAK T; SCHIFFER C; FEICKERT J; WELTE K; GANSER A; HERTENSTEIN B
      THE USE OF PROCALCITONIN (PCT) IN MONITORING PATIENTS AFTER AUTOLOGOUS AND ALLOGENEIC STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    79. ARSENIEV L; PICKERD N; GANSER A; HERTENSTEIN B
      EVALUATION OF CD34 MONOCLONAL-ANTIBODIES - COMPARISON OF DIFFERENT CLONES AND FLUOROCHROME CONJUGATES

      Bone marrow transplantation
    80. KARTHAUS M; HUBNER G; PORR J; NOVOTNY J; GEISSLER RG; HERTENSTEIN B; GANSER A
      CHANGES IN PORTAL BLOOD-FLOW IN AUTOLOGOUS PBSCT - VALUE OF SERIAL DUPLEX SONOGRAPHY (DUS) IN THE DIAGNOSIS OF VOD

      Bone marrow transplantation
    81. Schoffski, P; Weihkopf, T; Ganser, A
      Advanced head and neck cancer and clinical experience of an effective new agent: Docetaxel

      ANTICANCER RESEARCH
    82. WASSER S; BECKER S; HOSSLE JP; HAUSES M; OTT MG; DINAUER MC; GANSER A; HOELZER D; SEGER R; GREZ M
      RECONSTITUTION OF RESPIRATORY BURST ACTIVITY IN X-LINKED CHRONIC GRANULOMATOUS CELLS TO THERAPEUTICALLY RELEVANT LEVELS AFTER GENE-TRANSFERINTO BONE-MARROW CD34+ CELLS

      Molecular immunology
    83. KARTHAUS M; CARRATALA J; JURGENS H; GANSER A
      NEW STRATEGIES IN THE TREATMENT OF INFECTIOUS COMPLICATIONS IN HEMATOLOGY AND ONCOLOGY - IS THERE A ROLE FOR OUTPATIENT ANTIBIOTIC-TREATMENT OF FEBRILE NEUTROPENIA

      Chemotherapy
    84. KRAUTER J; PETER W; PASCHEBERG U; HEINZE B; BERGMANN L; HOELZER D; LUBBERT M; SCHLIMOK G; ARNOLD R; KIRCHNER H; PORT M; GANSER A; HEIL G
      DETECTION OF KARYOTYPIC ABERRATIONS IN ACUTE MYELOBLASTIC-LEUKEMIA - A PROSPECTIVE COMPARISON BETWEEN PCR FISH AND STANDARD CYTOGENETICS IN140 PATIENTS WITH DE-NOVO AML/

      British Journal of Haematology
    85. NOVOTNY JR; BATTMER K; STUCKI A; ARSENIEV L; BUNJES D; WIESNETH M; HALE G; GANSER A; HERTENSTEIN B
      EFFECTS OF DIFFERENT CD52 ANTIBODIES AND COMPLEMENT ON HEMATOPOIETIC PROGENITORS

      British Journal of Haematology
    86. FENCHEL K; HOFFMANN R; BORGHARDT J; KIRCHNER H; PRALLE H; GANSER A; ATZPODIEN J
      INTERLEUKIN-2 REDUCES THE CD4+ CELL DEPLETION FOLLOWING FLUDARABINE AND IDARUBICIN COMBINATION THERAPY

      British Journal of Haematology
    87. KRAUTER J; PASCHEBERG U; HEINZE B; BERGMANN L; HOELZER D; LUBBERT M; SCHLIMOK G; ARNOLD R; KIRCHNER H; PORT M; GANSER A; HELL G
      DETECTION OF CHROMOSOMAL-ABERRATIONS IN AML - COMPARISON OF RT-PCR FISH WITH STANDARD CYTOGENETICS/

      British Journal of Haematology
    88. HEIL G; KRAUTER J; BERGMANN L; HOELZER D; HOSSFELD D; MERTELSMANN R; NOENS L; SCHLIMOK G; PORT M; SCHWAB G; GANSER A
      RISK ADAPTED INDUCTION AND CONSOLIDATION THERAPY INCLUDING AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN ADULT DE-NOVO AML PATIENTS

      British Journal of Haematology
    89. HEIL G; HOELZER D; SANZ MA; LECHNER K; YIN JAL; PAPA G; NOENS L; SZER J; GANSER A; OBRIEN C; MATCHAM J; BARGE A
      A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE-III STUDY OF FILGRASTIM IN REMISSION INDUCTION AND CONSOLIDATION THERAPY FOR ADULTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML)

      British Journal of Haematology
    90. KRAUTER J; HEIDENREICH O; GANSER A; HELL G
      RIBOZYME-MEDIATED CLEAVAGE OF AML1 MTG8 FUSION-TRANSCRIPTS/

      British Journal of Haematology
    91. KARTHAUS M; ROSENTHAL C; HUEBNER G; PAUL H; ELSER C; SCHARMANN T; HERTENSTEIN B; KRAUTER J; GEISSLER RG; NOVOTNY J; HELL G; GANSER A
      RANDOMIZED PLACEBO-CONTROLLED TRIAL OF TOPICAL ORAL G-CSF (FILGRASTIM) IN HIGH-GRADE LYMPHOMA PATIENTS WITH SEVERE ORAL MUCOSITIS

      British Journal of Haematology
    92. HOFMANN WK; GANSER A; OTTMANN OG; SEIPELT G; ZANDER C; FISCHER JT; HOFFKEN K; HOFFMANN K; HOELZER D
      LONG-TERM COMPLETE REMISSIONS IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROMES DURING COMBINATION TREATMENT USING ALL-TRANS-RETINOIC ACID

      British Journal of Haematology
    93. KELL WJ; HOFMANN WK; HOELZER D; CHOMIENNE C; GANSER A; FENAUX P; CASTAIGNE S; BURNETT R; BURNETT AK
      9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA

      British Journal of Haematology
    94. NOVOTNY J; KADAR J; HERTENSTEIN B; SCHRODER D; PETERSEN D; ARSENIEV L; STANGEL W; GANSER A
      SUSTAINED DECREASE OF PERIPHERAL LYMPHOCYTES AFTER ALLOGENEIC BLOOD STEM-CELL APHERESES

      British Journal of Haematology
    95. HOFFMANN R; MULLER I; NEUBER K; LASSMANN S; BUER J; PROBST M; OEVERMANN K; FRANZKE A; KIRCHNER H; GANSER A; ATZPODIEN J
      RISK AND OUTCOME IN METASTATIC MALIGNANT-MELANOMA PATIENTS RECEIVING DTIC, CISPLATIN, BCNU AND TAMOXIFEN FOLLOWED BY IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON ALPHA2A

      British Journal of Cancer
    96. FRANZKE A; PROBSTKEPPER M; BUER J; DUENSING S; HOFFMANN R; WITTKE F; VOLKENANDT M; GANSER A; ATZPODIEN J
      ELEVATED PRETREATMENT SERUM LEVELS OF SOLUBLE VASCULAR CELL-ADHESION MOLECULE-1 AND LACTATE-DEHYDROGENASE AS PREDICTORS OF SURVIVAL IN CUTANEOUS METASTATIC MALIGNANT-MELANOMA

      British Journal of Cancer
    97. SCHOFFSKI P; WEIHKOPF T; GANSER A
      TAXOTERE(C) (DOCETAXEL) IN THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED AND METASTATIC HEAD AND NECK-CANCER

      British Journal of Cancer
    98. KARTHAUS M; HUEBNER G; GEISSLER RG; HEIL G; GANSER A
      HEPATIC-LESIONS OF CHRONIC DISSEMINATED SYSTEMIC CANDIDIASIS IN LEUKEMIA PATIENTS MAY BECOME VISIBLE DURING NEUTROPENIA - VALUE OF SERIAL ULTRASOUND EXAMINATIONS

      Blood
    99. KARTHAUS M; MERAN JG; WILKENS L; SOUDAH B; DIEDRICH H; KRAUTER J; GANSER A; HEIL G
      FLUORESCENCE IN-SITU HYBRIDIZATION AND SURFACE-MARKERS OF FINE-NEEDLEASPIRATION SPECIMEN CONFIRM EXTRAMEDULLARY MYELOBLASTOMA IN A PATIENTWITH CHRONIC MYELOID-LEUKEMIA

      Acta haematologica
    100. HERTENSTEIN B; ARSENIEV L; NOVOTNY J; GANSER A
      A COMPARATIVE REVIEW OF METHODS FOR T-CELL DEPLETION IN THE PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE

      Biodrugs


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 21:00:14